Glucagon in a sentence

In non-diabetics, glucagon levels are very low when insulin levels are high; however, those who have become diabetic no longer suppress glucagon output after eating.

In severe instances, they may lose consciousness and need emergent medical treatment with a medication known as glucagon.

The drugs work by suppressing appetite by mimicking the hormone glucagon-like peptide-1 (GLP-1), which is released after eating, making people feel so they eat less and lose weight.

The drug works as an appetite suppressant by mimicking a hormone called Glucagon-like peptide-1 (GLP-1).

These drugs belong to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which mimic the action of a naturally occurring hormone in the body that regulates blood sugar levels and appetite.

Breakthroughs in semaglutide and tirzepatide have given rise to several glucagon-like peptide-1 (GLP-1) medications, including Ozempic, Rybelsus, Wegovy, Mounjaro, and Zepbound.

Glucagon-like peptide 1 (GLP-1) agonists like Ozempic, Mounjaro, Wegovy improve metabolic health and promote weight loss.

Known also as tirzepatide and manufactured by Eli Lilly, Mounjaro is a glucagon-like peptide-1 (GLP-1) agonist, a group of drugs that assist in blood sugar management.

The drugs work by mimicking a natural hormone, glucagon-like peptide-1, which slows down the passage of food through the stomach, making people feel full for longer.

These medications work by mimicking a protein in your body called glucagon-like peptide 1 (GLP-1), explains, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA.

Tirzepatide ( Mounjaro ) activates both GLP-1 and GIP receptors while Retatrutide interacts with GLP-1, GIP and Glucagon receptors.

Check that you have enough supplies to manage your diabetes, including syringes, pens, insulin pump supplies, alcohol swabs, glucagon and anything else you need.

Delta cells make somatostatin, a hormone that is believed to control how the beta cells make and release insulin and how the alpha cells make and release glucagon.

Earl Sutherland explained in 1950, that the activity of phosphorylase was increased and thus glycogenolysis stimulated when liver slices were incubated with adrenalin and glucagon.

Fats stored in adipose tissue are released from the fat cells into the blood as free fatty acids and glycerol when insulin levels are low and glucagon and epinephrine levels in the blood are high.

Glucagon A hormone that raises the level of glucose (sugar) in the blood by forcing the liver to release some of its intracellular stores of glucose.

Glucagon and epinephrine also stimulate gluconeogenesis, which coverts non-carbohydrate substrates into G6P, which joins the G6P derived from glycogen, or substitutes for it when the liver glycogen store have been depleted.

Hypoglycemic symptoms and manifestations can be divided into those produced by the counterregulatory hormones ( epinephrine /adrenaline and glucagon) triggered by the falling glucose, and the neuroglycopenic effects produced by the reduced brain sugar.

Insulin is still secreted into the blood in response to the blood glucose level, but there seems to be a “resistance” to its actions, which may be, at least partly, due to the high glucagon concentrations in the blood.

In the liver, therefore, oxaloacetate is unavailable for condensation with acetyl-CoA when significant gluconeogenesis has been stimulated by low (or absent) insulin and high glucagon concentrations in the blood.